BORDONI, Valentina

BORDONI, Valentina  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.008 secondi).
Titolo Data di pubblicazione Autore(i) File
A comprehensive assessment of a new series of 5′,6′-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs) 1-gen-2021 Riu, F.; Sanna, L.; Ibba, R.; Piras, S.; Bordoni, V.; Scorciapino, M. A.; Lai, M.; Sestito, S.; Bagella, L.; Carta, A.
Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment 1-gen-2022 Marchesi, I.; Fais, M.; Fiorentino, F. P.; Bordoni, V.; Sanna, L.; Zoroddu, S.; Bagella, L.
Clarifying the molecular mechanism of tomentosin‑induced antiproliferative and proapoptotic effects in human multiple myeloma via gene expression profile and genetic interaction network analysis 1-gen-2021 Virdis, Patrizia; Migheli, Rossana; Bordoni, Valentina; Fiorentino, Francesco Paolo; Sanna, Luca; Marchesi, Irene; Pintore, Giorgio; Galleri, Grazia; Muroni, Maria Rosaria; Bagella, Luigi; Fozza, Claudio; De Miglio, Maria Rosaria; Podda, Luigi
Design, synthesis, and biological screening of a series of 4′-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs) 1-gen-2022 Riu, F; Ibba, R; Zoroddu, S; Sestito, S; Lai, M; Piras, S; Sanna, L; Bordoni, V; Bagella, L; Carta, A
Identification of 3-Aryl-1-benzotriazole-1-yl-acrylonitrile as a Microtubule-Targeting Agent (MTA) in Solid Tumors 1-gen-2024 Zoroddu, S.; Sanna, L.; Bordoni, V.; Weidong, L.; Gadau, S. D.; Carta, A.; Kelvin, D. J.; Bagella, L.
Immune Profiling of Polysaccharide Submicron Vesicles 1-gen-2018 Toma, Chiara C.; Aloisi, Alessandra; Bordoni, Valentina; Di Corato, Riccardo; Rauner, Martina; Cuniberti, Gianaurelio; Delogu, Lucia G.; Rinaldi, Rosaria
Long noncoding RNA SYISL: the crucial interaction with EZH2 in skeletal muscle differentiation and disorders 1-gen-2019 Bordoni, Valentina; Bagella, Luigi
Nanotechnology applications: from bone regeneration to cancer therapy 1-gen-2020 Bordoni, Valentina
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 1-gen-2022 Zoroddu, S.; Corona, P.; Sanna, L.; Borghi, F.; Bordoni, V.; Asproni, B.; Pinna, G. A.; Bagella, L.; Murineddu, G.
RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines 1-gen-2023 Zoroddu, Stefano; Sanna, Luca; Bordoni, Valentina; Lyu, Weidong; Murineddu, Gabriele; Pinna, Gerard A; Forcales, Sonia Vanina; Sala, Arturo; Kelvin, David J; Bagella, Luigi
Silver nanoparticles derived by artemisia arborescens reveal anticancer and apoptosis-inducing effects 1-gen-2021 Bordoni, V.; Sanna, L.; Lyu, W.; Avitabile, E.; Zoroddu, S.; Medici, S.; Kelvin, D. J.; Bagella, L.
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 1-gen-2020 Weidong, L.; Sanna, L.; Bordoni, V.; Tiansheng, Z.; Chengxun, L.; Murineddu, G.; Pinna, G. A.; Kelvin, D. J.; Bagella, L.
Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines 1-gen-2019 Sanna, L.; Piredda, R.; Marchesi, I.; Bordoni, V.; Forcales, S. V.; Calvisi, D. F.; Bagella, L.